Effective control of blood pressure levels in hypertensive patients is associated with a reduction in cardiovascular mortality and in the incidence of stroke, myocardial infarction and renal events. Yet, despite the use of combinations of antihypertensive drugs, blood pressure control cannot be obtained in a consistent proportion of patients.
In order to provide resistant hypertensive (“RH”) patients with optimal care, a holistic team approach for the decision-making process and appropriate use of these techniques is crucial.
This first RH Course is a joint initiative of the European Society of Hypertension (ESH), the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and PCR aiming to provide a forum for hypertension specialists, physicians caring for hypertensive patients, physicians performing catheter-based interventional medicine and other healthcare providers to reflect on the current state of knowledge and to share acquired experience.
This interactive and practical course is proposed as an open forum, where concerns can be expressed, answers found and consensus reached.
Our long-term common objectives are to help physicians, across multiple disciplines, all focused on the resistant hypertensive patient, uncover the answer to “what is the best management and technical strategy for my patient?” and ensure a successful integration of promising new technologies into their armamentarium.
We look forward to welcoming you in the fashionable city of Berlin, on 15th and 16th February 2013 and to the first Resistant Hypertension course, which promises to be stimulating and thought-provoking.
S. Kjeldsen, Chairman
F. Mahfoud, Chairman
R. Cífková, Steering Board Member
P-F. Plouin, Steering Board Member
R. Schmieder, Steering Board Member